Skip to main content
. 2013 Jun 12;49(5):814–824. doi: 10.1007/s00535-013-0839-5

Fig. 2.

Fig. 2

Use of aspirin formulations and prevalence of gastroduodenal ulcer and erosion in patients not treated with antiulcer drugs. In 690 participants who were not treated with antiulcer drugs, prevalence of gastroduodenal erosion and ulcer were compared between patients receiving enteric-coated (88.7 %) and buffered aspirin (11.3 %). AMB absence of mucosal break